Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-705498 for acute migraine pain
2005-004480-37Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of SB-705498 in migraine (3 arms), sponsored by GSK. Primary endpoint: Pain-free at 2 hours post-dose. Started Oct 2005; status: completed.
02
Drugs
SB-705498
03
Conditions
migraine
Beyond the preview
Go deeper on 2005-004480-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004480-37.